Clinical Trials
3 trialsNCT00352742 2008-10-28
A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma
Attenuon
Phase 1/2 Terminated
NCT00405574 2008-01-30
Study of ATN-224 in Patients With Prostate Cancer
Attenuon
Phase 2 Unknown
NCT00383851 2007-12-06
Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma
Attenuon
Phase 2 Unknown